The recent challenges in global supply have highlighted the value of securing vital medications like Ivermectin. Trusting on overseas manufacturers exposes countries to potential vulnerabilities, including transportation delays, price fluctuations, and even trade risks. Shifting towards domestic production of Ivermectin offers a multitude of advant